Francesca T. Aweeka

The penetration of anti-infectives into the central nervous system.

F. Aweeka, B. Kearney, Brian P. Kearney, 1999, Neurologic clinics.

Is there a pharmacokinetic interaction between foscarnet and zalcitabine during concomitant administration?

S. R. Brody, M. Jacobson, F. Aweeka, 1998, Clinical therapeutics.

Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions

T. Blaschke, F. Aweeka, A. Jayewardene, 2006, HIV medicine.

Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.

M. Jacobson, J. Mills, F. Aweeka, 1988, The Journal of infectious diseases.

Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics

S. Spector, F. Aweeka, E. Capparelli, 2008, HIV medicine.

Pharmacokinetics of intracellular zidovudine and its phosphorylated anabolites in the absence and presence of stavudine using an in vitro human peripheral blood mononuclear cell (PBMC) model.

S. R. Brody, F. Aweeka, Suzanne R. Brody, 1997, International journal of antimicrobial agents.

Lopinavir protein binding in HIV‐1‐infected pregnant women

M. Mirochnick, B. Best, C. Hu, 2010, HIV medicine.